Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial of Hepatic Artery Infusional Floxuridine With Systemic Chemotherapy in the Treatment of Pancreatic Cancer Liver Metastases

NCT03856658 is registered in ClinicalTrials.gov with Corewell Health West as lead sponsor.

NCT NCT03856658
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03856658 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial of Hepatic Artery Infusional Floxuridine With Systemic Chemotherapy in the Treatment of Pancreatic Cancer Liver Metastases
Lead sponsor
Corewell Health West
Phase
Phase 2
Overall status
Active, not recruiting
Start date
February 5, 2019
Completion date
December 31, 2028
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver metastases, pancreatic adenocarcinoma